Hermetica Superfood Encyclopedia
The Short Answer
Ziziphus mauritiana contains cyclopeptide alkaloids, flavonoids (notably epicatechin at up to 251 mg/100 g DW in fruits), and phenolic acids (quinic acid up to 902 mg/100 g DW in leaves) that modulate GABAergic pathways, inhibit α-glucosidase, and scavenge free radicals. Leaf extracts demonstrate strong antioxidant activity with DPPH IC50 values of 11.41–14.07 μg/mL, while in vitro α-glucosidase inhibition at 100 μg/mL suggests meaningful glycemic modulation potential pending clinical confirmation.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary KeywordZiziphus mauritiana benefits
Indian Jujube — botanical close-up
Health Benefits
**Sedative and Sleep Support**
Cyclopeptide alkaloids, particularly mauritine and amphibine classes found in leaves and seeds, are postulated to interact with GABAergic receptors, supporting the traditional Malay use of Z. mauritiana decoctions for insomnia and anxiety relief.
**Antioxidant Protection**
Leaf extracts achieve DPPH radical scavenging IC50 values of 11.41–14.07 μg/mL, attributable to high concentrations of catechin (up to 296 mg/100 g DW), rutin, and quercetin that donate hydrogen atoms or electrons to neutralize reactive oxygen species.
**Glycemic Regulation**
Methanolic leaf extracts inhibit α-glucosidase activity at 100 μg/mL and DPP-IV at 1,000 μg/mL, suggesting dual-enzyme modulation of postprandial glucose absorption relevant to type 2 diabetes management.
**Antimicrobial Activity**
Phytochemicals in methanolic leaf extracts, including phenolic acids such as p-coumaric acid (up to 15.67 mg/100 g DW) and chlorogenic acid, disrupt microbial membrane integrity and have demonstrated in vitro activity against bacterial and fungal pathogens.
**Anti-inflammatory Potential**
Flavonoids including apigenin and naringin (up to 37.68 mg/100 g DW) suppress pro-inflammatory enzyme activity and cytokine signaling pathways, consistent with traditional topical and oral uses for inflammatory conditions.
**Nutritional and Hepatoprotective Support**
The fruit provides vitamin C, total carotenoids with high in vitro bioaccessibility (85.89%), and α-tocopherol (3.92% of leaf fatty acid fraction), contributing to oxidative stress reduction associated with liver protection.
**Cardiovascular Risk Reduction**: γ-Sitosterol (2
72% in leaf lipid fraction) competes with dietary cholesterol for intestinal absorption, and α-linolenic acid (14.21% of leaf fatty acids) supports an anti-atherogenic lipid profile in preclinical contexts.
Origin & History
Natural habitat
Ziziphus mauritiana Lam. is native to tropical and subtropical Asia, with its center of diversity spanning South Asia, Southeast Asia, and extending into northern Australia and parts of Africa. It thrives in semi-arid to arid conditions, tolerating poor soils, drought, and temperatures up to 50°C, making it a resilient fruit tree cultivated extensively across India, Malaysia, Thailand, and West Africa. Traditional cultivation favors low-altitude plains and scrubland regions, where the tree is grown both as a wild-collected resource and in managed orchards for its edible fruits, medicinal leaves, and bark.
“Ziziphus mauritiana occupies a significant role in Malay ethnomedicine, where it is known as 'bidara' and used in ritual cleansing (mandi bunga), treatment of insomnia, fever reduction, and wound healing — practices documented in Malay traditional medicine manuscripts and community health surveys across peninsular Malaysia. In South Asian Ayurvedic and Unani traditions, the fruit (called 'ber') is described in classical texts including Charaka Samhita as a tonic for debility, heart complaints, and digestive disorders, while the bark and leaves serve as astringents and anti-inflammatory agents. In West African ethnomedicine, particularly in the Sahel region, the leaves are prepared as poultices for skin infections and the fruit consumed to combat malnutrition given its vitamin C and energy content. The tree also holds cultural-spiritual significance in Islamic tradition — the sidr tree referenced in the Quran is identified by many scholars with Ziziphus species, lending it sacred status in parts of the Arab world and among Muslim communities in Southeast Asia.”Traditional Medicine
Scientific Research
The current body of research on Z. mauritiana consists almost exclusively of in vitro phytochemical characterization and bioassay studies, with no published randomized controlled trials (RCTs) or formal human clinical trials identified in peer-reviewed literature as of 2024. Key studies include LC-ESI-MS and HPLC metabolite profiling of leaves and fruits across geographic populations, DPPH and CUPRAC antioxidant assays yielding quantified IC50 values, and enzyme inhibition assays against α-glucosidase and DPP-IV — all conducted at the cell-free or cellular level without in vivo validation. Animal studies examining sedative alkaloid fractions exist for the closely related Ziziphus jujuba and Ziziphus spinosa, providing mechanistic analogy but not direct translational evidence for Z. mauritiana. The overall evidence base is preliminary, and extrapolation to therapeutic recommendations for humans requires significant caution pending properly designed preclinical dose-escalation and clinical phase studies.
Preparation & Dosage
Traditional preparation
**Traditional Malay Decoction (Leaves)**
A handful of fresh or dried leaves boiled in 2–3 cups of water for 15–20 minutes, consumed as a warm tea before sleep for insomnia; no standardized dose established.
**Methanolic/Ethanolic Leaf Extract (Research Grade)**
Used at 100–1,000 μg/mL in in vitro assays; no equivalent human oral dose has been validated or extrapolated.
**Dried Fruit Powder**
231–251 mg/100 g DW) and chlorogenic acid (~16–34 mg/100 g DW) but no therapeutic dose range is defined
Consumed as food or mixed into preparations; fruits provide epicatechin (~.
**Standardized Extract**
No commercially standardized Z. mauritiana supplement with defined alkaloid or flavonoid content exists as an established product category as of current literature review.
**Timing Note**
Ethnobotanically, leaf preparations for insomnia are administered in the evening; antidiabetic preparations are traditionally taken before meals, consistent with α-glucosidase inhibition rationale.
**Form Consideration**
95 mg GAE/100 g DW) and antioxidant capacity than fruits or bark, making leaf-derived preparations the most bioactively concentrated form documented
Leaves consistently yield higher total phenolics (532..
Nutritional Profile
Fruits of Z. mauritiana provide moderate carbohydrate content (~70–80% of DW as sugars and fiber), vitamin C (up to 76 mg/100 g fresh weight in some cultivars), and carotenoids with high in vitro bioaccessibility (85.89%). Key phenolic compounds in fruits include epicatechin (231–251 mg/100 g DW) and chlorogenic acid (16–34 mg/100 g DW), with total flavonoids highest in leaves (~90–92 mg QE/100 g DW). Leaf lipid fractions contain palmitic acid (38.55%), α-linolenic acid (14.21%), γ-sitosterol (2.72%), and α-tocopherol (3.92%), while total phenolics in leaves reach 532.95 mg GAE/100 g DW with quinic acid as the dominant individual compound (up to 902 mg/100 g DW). Bioavailability of fat-soluble compounds (carotenoids, tocopherols) is expected to be enhanced when consumed with dietary fat, though no formal human pharmacokinetic studies have been conducted for Z. mauritiana specifically.
How It Works
Mechanism of Action
The cyclopeptide alkaloids of Z. mauritiana — including mauritine A–D and nummularine classes — are structurally similar to those in Ziziphus spinosa, which have documented positive allosteric modulation of GABA-A receptors, thereby potentiating chloride ion influx, neuronal hyperpolarization, and anxiolytic-sedative effects central to its ethnopharmacological use in Malay insomnia treatment. Flavonoids such as quercetin and epicatechin exert antioxidant effects via hydrogen atom transfer and single electron transfer to DPPH and ABTS radicals, while quercetin additionally inhibits NF-κB translocation and COX-2 expression, dampening the inflammatory cascade at the transcription factor level. α-Glucosidase inhibition by phenolic constituents involves competitive or mixed-mode binding to the enzyme's active site at the brush border of the small intestine, slowing carbohydrate hydrolysis and blunting postprandial hyperglycemia, while DPP-IV inhibition at higher extract concentrations prolongs incretin hormone (GLP-1, GIP) half-life to enhance insulin secretion. γ-Sitosterol reduces cholesterol absorption through competitive displacement of micellar cholesterol in the intestinal lumen, and p-coumaric acid chelates metal ions to suppress Fenton reaction-derived hydroxyl radical generation.
Clinical Evidence
No clinical trials with enrolled human participants, defined primary endpoints, or reported effect sizes have been conducted specifically on Z. mauritiana extracts or isolated compounds. Existing data derives from in vitro bioassays (DPPH IC50, enzyme inhibition at defined extract concentrations), in vitro bioaccessibility studies (carotenoid bioavailability 85.89%), and comparative phytochemical profiling across plant organs and geographic origins. Mechanistic inferences regarding sedation, glycemic control, and antioxidant efficacy are therefore extrapolated from chemical characterization and structural analogy with pharmacologically better-studied congeners such as Z. jujuba. Confidence in clinically meaningful outcomes is low, and formal efficacy and safety conclusions cannot be drawn without human trial data.
Safety & Interactions
Formal toxicological studies and safety assessments for Z. mauritiana extracts in humans are absent from the published literature, and no established maximum safe dose, adverse effect profile, or no-observed-adverse-effect level (NOAEL) has been defined for any preparation. In vitro bioassays at concentrations up to 1,000 μg/mL have not reported cytotoxicity, and the fruit is consumed as a food across multiple cultures without documented acute toxicity, suggesting a reasonable food-level safety margin. Given the postulated GABAergic mechanism of its cyclopeptide alkaloids, co-administration with CNS depressants (benzodiazepines, barbiturates, opioids, alcohol) represents a theoretical pharmacodynamic interaction risk warranting clinical caution. Pregnant and lactating women should avoid concentrated leaf or seed extracts in the absence of safety data, though moderate fruit consumption as food is unlikely to pose risk; individuals on hypoglycemic medications should monitor blood glucose if using preparations with demonstrated α-glucosidase inhibitory activity.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ziziphus mauritiana Lam.Indian jujubeChinese applebidara (Malay)ber (Hindi/Urdu)sidr (Arabic)Rhamnus jujuba var. mauritianadunks (Caribbean)
Frequently Asked Questions
What is Ziziphus mauritiana used for in traditional Malay medicine?
In traditional Malay ethnomedicine, Z. mauritiana (known as 'bidara') is most commonly used as a treatment for insomnia and anxiety, with leaves prepared as a decoction taken before sleep. The plant also features in ritual spiritual cleansing ceremonies (mandi bunga) and is applied topically for fever reduction and wound healing, reflecting its broad therapeutic role in Malay healing traditions.
What are the main bioactive compounds in Ziziphus mauritiana?
The principal bioactives include cyclopeptide alkaloids (mauritine and nummularine classes) responsible for proposed sedative effects, flavonoids such as epicatechin (up to 251 mg/100 g DW in fruit) and quercetin, and phenolic acids including quinic acid (up to 902 mg/100 g DW in leaves) and chlorogenic acid. Leaves consistently contain the highest total phenolic content (532.95 mg GAE/100 g DW) and antioxidant activity of any plant organ.
Does Ziziphus mauritiana help with blood sugar control?
In vitro studies show that methanolic leaf extracts inhibit α-glucosidase at 100 μg/mL and DPP-IV at 1,000 μg/mL, two key enzymes involved in postprandial glucose regulation — mechanisms similar to pharmaceutical agents acarbose and sitagliptin respectively. However, no human clinical trials have confirmed these effects in people with diabetes or prediabetes, so current evidence is limited to laboratory findings and cannot support therapeutic recommendations.
Is Ziziphus mauritiana the same as Ziziphus jujuba?
No, they are distinct species: Ziziphus mauritiana Lam. (Indian jujube, bidara) is a tropical/subtropical species native to South and Southeast Asia, whereas Ziziphus jujuba Mill. (Chinese jujube, da zao) originates from temperate China and has a much more extensive clinical research record, including RCTs. They share some alkaloid classes and flavonoids, but differ in fruit morphology, traditional uses, and the depth of pharmacological evidence available.
What is the safe dosage of Ziziphus mauritiana extract?
No established safe supplemental dose for Z. mauritiana extract has been determined through clinical trials or formal toxicological evaluation in humans. Fruit consumption at food quantities is considered safe based on widespread traditional use, and in vitro studies have not shown cytotoxicity at concentrations up to 1,000 μg/mL. Individuals taking CNS depressants or blood sugar-lowering medications should consult a healthcare provider before using concentrated leaf or seed extracts due to theoretical pharmacodynamic interaction risks.
Does Ziziphus mauritiana interact with sedative or anti-anxiety medications?
Ziziphus mauritiana contains cyclopeptide alkaloids (mauritine and amphibine) that may interact with GABAergic pathways, similar to prescription sedatives and benzodiazepines. Concurrent use with medications like diazepam, alprazolam, or other CNS depressants could potentially potentiate sedative effects and should be discussed with a healthcare provider. Clinical interaction studies are limited, making caution advisable when combining with pharmaceutical sedatives.
Is Ziziphus mauritiana safe to use during pregnancy or while breastfeeding?
Safety data for Ziziphus mauritiana use during pregnancy and lactation is insufficient, and traditional use does not guarantee safety in these populations. The presence of bioactive alkaloids and lack of human clinical trials in pregnant or nursing women means it should be avoided or used only under medical supervision during these periods. Pregnant and breastfeeding women should consult a healthcare provider before supplementing.
What form of Ziziphus mauritiana extract provides the strongest antioxidant activity?
Leaf extracts of Ziziphus mauritiana demonstrate the most potent antioxidant activity, with DPPH radical scavenging IC50 values of 11.41–14.07 μg/mL, making them superior to seed or fruit extracts for this benefit. Ethanol and aqueous leaf extracts are typically used in research to achieve these antioxidant concentrations. The choice between extract types should consider both antioxidant potency and intended health outcome (sleep support vs. antioxidant protection).
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ziziphus-mauritiana-ziziphus-mauritiana-lam curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
